|
Volumn 47, Issue 3, 2017, Pages 61-68
|
Long-term safety and tolerability of valbenazine (NBI-98854) in subjects with tardive dyskinesia and a diagnosis of schizophrenia or mood disorder
a b c c c |
Author keywords
Antipsychotic agents; Bipolar disorder; Depression; Double blind method; Mood disorders; Psychiatric status rating scales; Psychopathology; Psychopharmacology; Psychotic disorders; Schizophrenia; Tardive dyskinesia; Valbenazine
|
Indexed keywords
PLACEBO;
VALBENAZINE;
ADRENERGIC RECEPTOR AFFECTING AGENT;
NEUROLEPTIC AGENT;
SLC18A2 PROTEIN, HUMAN;
TETRABENAZINE;
VALINE;
VESICULAR MONOAMINE TRANSPORTER;
ADULT;
ANXIETY DISORDER;
ARTHRALGIA;
ARTICLE;
BACKACHE;
BARNES AKATHISIA SCALE;
BRONCHITIS;
CALGARY DEPRESSION SCALE;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIARRHEA;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ELECTROCARDIOGRAPHY;
EXTRAPYRAMIDAL SYMPTOM;
FATIGUE;
FEMALE;
HEADACHE;
HUMAN;
LONG TERM EXPOSURE;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
MONTGOMERY ASBERG DEPRESSION RATING SCALE;
NAUSEA;
PHASE 3 CLINICAL TRIAL;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PSYCHOPHARMACOTHERAPY;
RISK ASSESSMENT;
SCHIZOAFFECTIVE PSYCHOSIS;
SIDE EFFECT;
SOMNOLENCE;
SUICIDAL IDEATION;
TARDIVE DYSKINESIA;
TREATMENT DURATION;
URINARY TRACT INFECTION;
VOMITING;
YOUNG MANIA RATING SCALE;
ADVERSE DRUG REACTION;
AGED;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
CHEMICALLY INDUCED;
FOLLOW UP;
MOOD DISORDER;
OUTCOME ASSESSMENT;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
ADRENERGIC UPTAKE INHIBITORS;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LONG TERM ADVERSE EFFECTS;
MALE;
MIDDLE AGED;
MOOD DISORDERS;
OUTCOME ASSESSMENT (HEALTH CARE);
PSYCHOTIC DISORDERS;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TETRABENAZINE;
VALINE;
VESICULAR MONOAMINE TRANSPORT PROTEINS;
|
EID: 85028352306
PISSN: 00485764
EISSN: 24722448
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (18)
|
References (2)
|